AI Summary
Description
General Information Document Type: Presolicitation Synopsis Number: 75N98026Q00617 Posted Date: June 12, 2026 Original Response Date: June 22, 2026 Current Response Date: June 22, 2026 Set Aside: N/A NAICS Code: 334516 Contracting Office Address National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817 Description INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: 3100 Smith Farm RD PO Box 200 Matthews, North Carolina 28104 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 334516 with a Size Standard $1000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION Title: Procurement of CEM Peptide synthesizer Liberty Blue 2.0 Background Information: The peptide synthesizer is required for expeditious synthesis of peptides for therapeutic testing and use, The Liberty Blue™ 2.0 System is an automated microwave peptide synthesizer designed for Fmoc solid phase peptide synthesis from 0.005 - 5mmol scale using reaction vessels ranging from 30-125 mL volume. The Liberty Blue™ 2.0 uses a Discover® single mode microwave reactor that provides for self-tuning with a continuous power delivery from 0-300 W in 1 W increments. The system contains (20) ports stand for amino acids,(7) additional unusual amino acid ports, and (4) external ports for other reagents. All reagent deliveries are controlled by nitrogen pressure. Amino acid and activation reagents are delivered with the Flex-Add™ technology allowing for precise and accurate delivery. Includes innovative headspace cleaning process which fosters a cleaner reaction vessel environment and provides unprecedented levels of peptide purity. Includes:- Camera Option - Provides the ability to view reactions as the…
Classification
Place of Performance
Contracting Office
Contacts